Table 4.
Correlation between CCNDBP1 expression and clinicopathological characteristics of patients (N = 46).
| Variables | Low expression (N = 21) | High expression (N = 25) | P-value |
|---|---|---|---|
| Gender | |||
| Male | 11 | 12 | 0.7672 |
| Female | 10 | 13 | |
| Age (years) | 59.57 ± 11.33 | 57.44 ± 12.63 | 0.5534 |
| Tumor size (cm) | 16.70 ± 11.49 | 14.41 ± 9.49 | 0.4624 |
| Tumor site | |||
| Trunk | 1 | 4 | 0.2372 |
| Limb | 2 | 5 | |
| Retroperitoneum | 18 | 16 | |
| Operation times | |||
| 1 time | 12 | 11 | 0.3745 |
| ≥2 times | 9 | 14 | |
| AJCC anatomic stage | |||
| Stage II | 2 | 3 | 0.1730 |
| Stage IIIA | 4 | 10 | |
| Stage IIIB | 7 | 9 | |
| Stage IV | 8 | 3 | |
| T classification | |||
| T1 | 2 | 3 | 0.5253 |
| T2 | 5 | 9 | |
| T3 | 6 | 3 | |
| T4 | 8 | 10 | |
| N classification | |||
| N0 | 19 | 23 | 0.7319 |
| N1 | 2 | 2 | |
| M classification | |||
| M0 | 14 | 24 | 0.0261* |
| M1 | 7 | 1 | |
| Histologic grade | |||
| G2 | 8 | 9 | 0.8834 |
| G3 | 13 | 16 |
AJCC, American Joint Committee on Cancer. *P < 0.05.